Sodium nitroprusside
NDC 67457-839, Sodium nitroprusside, injection, solution, concentrate, from Mylan Institutional LLC.
- Product NDC
- 67457-839
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210763
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-839 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM NITROPRUSSIDE25 mg/mL
Pharmacologic classes
Vasodilation [PE]; Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-839-02 | 67457083902 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-839-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6fbfb86c-da8d-4741-b1e0-7000e2bbad5f
Use it
Look up 67457-839 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-839 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-839. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.